You are here:
Publication details
Pyrazolo[1,5-a]pyrimidines as orally available inhibitors of cyclin-dependent kinase 2
| Authors | |
|---|---|
| Year of publication | 2007 |
| Type | Peer-reviewed scientific article |
| Magazine / Source | Bioorganic & Medicinal Chemistry Letters |
| MU Faculty or unit | |
| Citation | |
| web |
|
| Field | Pharmacology and pharmaceutical chemistry |
| Keywords | CDK2 kinase; inibitor; cancer |
| Description | Properly substituted pyrazolo[1,5-a]pyrimidines are potent and selective CDK2 inhibitors. Compound 15j is orally available and showed efficacy in a mouse A2780 xenograft model. |